blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1517685

EP1517685 - 2-(PHENYL)-2H-PYRAZOLE-3-CARBOXYLIC ACID-N-4-(THIOXO-HETEROCYCLYL)-PHENYL-AMIDE DERIVATIVES AND CORRESPONDING IMINO-HETEROCYCLYL DERIVATIVES AND RELATES COMPOUNDS FOR USE AS INHIBITORS OF THE COAGULATION FACTORS XA AND/OR VIIA FOR TREATING THROMBOSES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.08.2007
Database last updated on 13.11.2024
Most recent event   Tooltip17.08.2007Application deemed to be withdrawnpublished on 19.09.2007  [2007/38]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[N/P]
Former [2005/13]For all designated states
MERCK PATENT GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
Inventor(s)01 / CEZANNE, Bertram
Bahnstrasse 74
64546 Mörfelden-Walldorf / DE
02 / DORSCH, Dieter
Königsberger Strasse 17A
64372 Ober-Ramstadt / DE
03 / MEDERSKI, Werner
Katzenellnbogenweg 1
64673 Zwingenberg / DE
04 / TSAKLAKIDIS, Christos
Im Langgewann 54
69469 Weinheim / DE
05 / GLEITZ, Johannes
Liebigstrasse 26
64293 Darmstadt / DE
06 / BARNES, Christopher
Sperberstrasse 109A
65812 Bad Soden / DE
 [2005/13]
Application number, filing date03732540.405.06.2003
[2005/13]
WO2003EP05898
Priority number, dateDE200212907028.06.2002         Original published format: DE 10229070
[2005/13]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2004002477
Date:08.01.2004
Language:DE
[2004/02]
Type: A1 Application with search report 
No.:EP1517685
Date:30.03.2005
Language:DE
The application published by WIPO in one of the EPO official languages on 08.01.2004 takes the place of the publication of the European patent application.
[2005/13]
Search report(s)International search report - published on:EP08.01.2004
ClassificationIPC:A61K31/4155, A61K31/4178, A61K31/433, A61K31/42, C07D403/12, C07D417/12, C07D413/14, C07D403/14
[2005/13]
CPC:
C07D403/12 (EP,US); A61K31/4155 (EP,US); A61K31/4178 (EP,US);
A61K31/42 (EP,US); A61K31/433 (EP,US); A61P25/06 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P35/04 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P9/08 (EP);
A61P9/10 (EP); C07D403/14 (EP,US); C07D413/14 (EP,US);
C07D417/12 (EP,US); Y02P20/55 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/13]
Extension statesALNot yet paid
LT21.10.2004
LV21.10.2004
MKNot yet paid
TitleGerman:2-(PHENYL)-2H-PYRAZOL-3-CARBONSÄURE-N-4-(THIOXO-HETEROCYCLYL)-PHENYL-AMID DERIVATE UND ENTSPRECHENDE IMINO-HETEROCYCLYL DERIVATE SOWIE VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER KOAGULATIONSFAKTOREN XA UND/ODER VIIA ZUR BEHANDLUNG VON THROMBOSEN[2005/13]
English:2-(PHENYL)-2H-PYRAZOLE-3-CARBOXYLIC ACID-N-4-(THIOXO-HETEROCYCLYL)-PHENYL-AMIDE DERIVATIVES AND CORRESPONDING IMINO-HETEROCYCLYL DERIVATIVES AND RELATES COMPOUNDS FOR USE AS INHIBITORS OF THE COAGULATION FACTORS XA AND/OR VIIA FOR TREATING THROMBOSES[2005/13]
French:DERIVES DE 2-(PHENYL)-2H-PYRAZOL-3-ACIDE CARBOXYLIQUE-N-4-(THIOXO-HETEROCYCLYL)-PHENYL-AMIDE, DERIVES D IMINO-HETEROCYCLYLE C ORRESPONDANTS ET COMPOSES DERIVES SERVANT D INHIBITEURS DES FACTEURS DE COAGULATION XA ET/OU VIIA DANS LE TRAITEMENT DE THROMBOSES[2005/13]
Entry into regional phase21.10.2004National basic fee paid 
21.10.2004Designation fee(s) paid 
21.10.2004Examination fee paid 
Examination procedure11.12.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.10.2004Examination requested  [2005/13]
04.04.2005Despatch of a communication from the examining division (Time limit: M06)
20.08.2005Reply to a communication from the examining division
05.10.2005Despatch of a communication from the examining division (Time limit: M04)
07.01.2006Reply to a communication from the examining division
08.05.2006Despatch of a communication from the examining division (Time limit: M04)
14.07.2006Reply to a communication from the examining division
17.11.2006Communication of intention to grant the patent
28.03.2007Application deemed to be withdrawn, date of legal effect  [2007/38]
03.05.2007Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2007/38]
Divisional application(s)EP06000157.5  / EP1679073
Fees paidRenewal fee
14.06.2005Renewal fee patent year 03
27.03.2006Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.06.200705   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9828269  (DU PONT MERCK PHARMA [US]) [X] 1-33 * the whole document * * z.B. Beispiel 241 *;
 [X]WO9857937  (DU PONT MERCK PHARMA [US]) [X] 1-33 * the whole document * * z.B. Beispiel 21 *;
 [X]WO9857951  (DU PONT MERCK PHARMA [US]) [X] 1-33 * the whole document ** z.B. Beispiel 68 ERFINDUNG 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.